Stay updated with breaking news from Robertm Plenge. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ellsworth Advisors LLC lifted its holdings in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 4.8% in the second quarter, HoldingsChannel reports. The firm owned 10,623 shares of the biopharmaceutical company’s stock after buying an additional 482 shares during the quarter. Ellsworth Advisors LLC’s holdings in Bristol-Myers Squibb were worth $679,000 as of its most recent […]
Edmp Inc. cut its position in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 0.4% in the 2nd quarter, Holdings Channel.com reports. The institutional investor owned 45,395 shares of the biopharmaceutical company’s stock after selling 198 shares during the period. Bristol-Myers Squibb makes up about 2.8% of Edmp Inc.’s investment portfolio, making the stock its 11th […]
Achmea Investment Management B.V. lifted its position in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 9.5% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 445,183 shares of the biopharmaceutical company’s stock after purchasing an additional 38,793 […]
Weatherly Asset Management L. P. lessened its stake in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 3.7% during the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 4,597 shares of the biopharmaceutical company’s stock after selling 175 shares during the period. Weatherly Asset Management L. P.’s […]
Annex Advisory Services LLC lessened its holdings in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 1.3% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 114,727 shares of the biopharmaceutical company’s stock after selling 1,516 shares during the period. Annex Advisory […]